文献速递脑血管病

内皮祖细胞对脑血管病结局的影响

Influence of Endothelial Progenitor Cells on Outcomes in Cerebrovascular Disease.
PubMed 文献 · Stroke · 2025-08-06

在西班牙单中心前瞻性观察126例脑血管病患者,于症状出现48小时内、第7天和12周定量循环内皮祖细胞(EPC)。第7天EPC较高与3个月良好功能结局独立相关,并与入院卒中严重度和住院时长呈负相关,随访死亡者第7天EPC显著更低。

要点

  • 第7天EPC较高与3个月良好功能结局独立相关。
  • 第7天EPC与入院卒中严重度及住院时长呈负相关。
  • 随访死亡者第7天EPC显著低于存活者。

核心结论

  • 第7天EPC水平可能作为脑血管病恢复和死亡的预后生物标志物。
  • 结果提示靶向内皮修复机制可能存在治疗时间窗。

研究设计与样本

  • 前瞻性观察研究,在西班牙Hospital Universitario de Gran Canaria Doctor Negrín于2023年9月至2024年6月开展。
  • 纳入126例脑血管病患者(平均年龄70.4±12.9岁;58.7%男性),症状出现48小时内招募。
  • 在入院(<48小时)、第7天和12周定量循环EPC水平。

主要发现

  • 第7天EPC较高与3个月良好功能结局独立相关(OR 0.769 [95%CI 0.605-0.977];P=0.032)。
  • 第7天EPC与入院卒中严重度(r=-0.205;P=0.034)和住院时长(r=-0.253;P=0.008)呈显著负相关。
  • 随访期间死亡患者第7天EPC显著低于存活者(平均秩44.40 vs 56.34;P=0.004)。
  • 缺血性卒中亚组中,第7天EPC仍为良好结局的独立预测因子(OR 0.743 [95%CI 0.570-0.968];P=0.028)、更短住院(r=-0.278;P=0.006)和生存(U=552.000;P=0.043)的预测因子。

关键数值与推荐

  • 主要结局为3个月良好功能状态(改良Rankin量表评分0-2)。
  • 次要结局包括卒中严重度(美国国立卫生研究院卒中量表)、住院时长和死亡率。

临床怎么用

  • 第7天EPC水平或可用于辅助判断脑血管病患者3个月功能恢复和死亡风险。
  • 结果提示内皮修复机制可能存在治疗干预时间窗,尚需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endothelial progenitor cells (EPCs) contribute to vascular repair and may play a critical role in recovery following cerebrovascular disease. This study aimed to evaluate the association between circulating EPC levels and clinical outcomes in patients with ischemic stroke, hemorrhagic stroke, and transient ischemic attack. METHODS: We conducted a prospective observational study at Hospital Universitario de Gran Canaria Doctor Negrín (Spain) between September 2023 and June 2024. We evaluated the association between circulating EPC levels and clinical outcomes in 126 patients with cerebrovascular disease (mean age, 70.4±12.9 years; 58.7% male), recruited within 48 hours of symptom onset. EPCs were quantified at admission (<48 hours), day 7, and 12 weeks. The primary outcome was favorable functional status at 3 months (modified Rankin Scale score, 0-2). Secondary outcomes included stroke severity (National Institutes of Health Stroke Scale), hospital stay, and mortality. RESULTS: Higher EPC levels on day 7 were independently associated with favorable functional outcome at 3 months (odds ratio, 0.769 [95% CI, 0.605-0.977]; P=0.032). Significant negative correlations were found between EPCs at day 7 and stroke severity at admission (r=-0.205; P=0.034) and length of hospital stay (r=-0.253; P=0.008). EPCs at day 7 were significantly lower in patients who died during follow-up (mean rank, 44.40 versus 56.34; P=0.004). Subgroup analysis in patients with ischemic stroke confirmed that day-7 EPC levels remained an independent predictor of good outcome (odds ratio, 0.743 [95% CI, 0.570-0.968]; P=0.028), shorter hospitalization (r=-0.278; P=0.006), and survival (U=552.000; P=0.043). CONCLUSIONS: EPC levels at day 7 may serve as a prognostic biomarker for recovery and mortality in cerebrovascular disease. These findings suggest a potential therapeutic window targeting endothelial repair mechanisms.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. García Granado JF, González Hernández AN, Rodríguez Esparragón FJ, et al. Influence of Endothelial Progenitor Cells on Outcomes in Cerebrovascular Disease. Stroke. 2025. PMID: 40765503. doi:10.1161/STROKEAHA.125.052464

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。